David Traylor has joined boutique I-bank Headwaters as a managing director within the firm’s life sciences group. He previously was with Caris & Company.
Headwaters announced that Mr. David W. Traylor has joined the firm as a Managing Director within their Life Sciences Group.
David W. Traylor joined Headwaters from Caris & Company where he was focused on capital formation for biopharmaceutical and device companies. He also previously worked at Wedbush Pacific Growth, advising private and public biotechnology and medical device companies in various transactions including IPOs, public offerings, private offerings, mergers and acquisitions.
David began his career in the research department at Somatogen, a company pursuing a recombinant blood substitute. Following that, he led the management of programs at Affymetrix, the leading innovator in microarray technology. He also held senior business development positions at Atugen and BioSeek.
“David possesses a rare combination of scientific background and transaction experience to deliver great investment banking service to this client base,” offered Philip W. Seefried, the Co-Founder & CEO of Headwaters. “His talents coupled with the Life Sciences team’s access to institutional capital combine to form a powerful capital creation engine for this dynamic industry.”
David received B.A. degrees from the University of Colorado Boulder in Molecular and Cellular Biology and Biochemistry and an M.B.A. from the Leeds School of Business at the University of Colorado Boulder. He is also an inventor with two issued U.S. patents.
The Life Sciences Group produces a comprehensive quarterly research report on the Healthcare sector. If you are interested in receiving this report, please click here to contact the team and request a copy.